C.L. Slingluff

Type de document

Co-auteur

E. Wang

D.E. Speiser

S.M. Shea

E.P. Salerno

J. Pinczewski

J.M. Obeid

I.S. Mauldin

F.M. Marincola

T.F. Gajewski

D.H. Deacon

G. Coukos

D. Bedognetti

Date

Source

Serveur académique Lausannois (2)

Mot-clé

cancer (2) Cancer (2) Series (2) Cancer (2) puits (1) tissu (corporel) (1) thérapie (1) norme (1) peau (1) risque (1) association (1) nouvelle technologie (1) besoin (1) mortalité (1) surveillance (1) gestion (1) infiltration (1) coût (1) abords (agglomération) (1) taux (1) calcium (1) survie (1) Monitoring (1) Mortality (1) Development (1) Treatment (1) Article (1) Prevention (1) Genes (1) Interleukin-2 (1)

Documents écrit par C.L. Slingluff (2) | parle de C.L. Slingluff (0)

Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk.

E.P. Salerno et al. (2016)

Progress and controversies in developing cancer vaccines.

C.L. Slingluff et al.